Stay up to date with the latest research, tips, and trends in fitness, nutrition, and weight management.
Researchers at Yale University have identified a low-cost prescription drug that may be able to help “reverse” disruptive behaviors in some people with autism spectrum disorder.
The IMPACTS-BP trial showed that SPRINT-like reductions in systolic BP are possible even in tough real-world scenarios.
Sleep problems, common in SMA, may involve both nighttime breathing issues linked to muscle weakness and brain changes, per a study.
Friends of the Cancer Centre’s Fermanagh fundraising group has raised £89,500 over the past 12 months to support families affected by cancer.
Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits. Scientists are now pushing toward multi-pronged strategies, from gene editing to brain-cell rejuvenation and gut health interventions. The goal: stop treating Alzheimer’s as one disease and start tackling it as a complex system.
A major review finds no evidence that asbestos-free talc increases cancer risk, helping clarify long-standing concerns about occupational exposure.
Heart failure affects more than 64 million people worldwide (1%–3% in the general adult population) and its prevalence is projected to increase. This
Young-onset Parkinson's disease begins before individuals reach their 50th birthday and presents both medical and emotional difficulties
New studies from 23andMe suggest genetic variation may modestly influence GLP-1 weight-loss response and side effects.
A growing amount of research is investigating how psychedelics might be used to treat depression and other disorders, and now a new study highlights a "neural fingerprint" that's common across five well-known mind-altering drugs.